A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study.
about
A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A phase II evaluation of briva ...... ecologic Oncology Group study.
@en
type
label
A phase II evaluation of briva ...... ecologic Oncology Group study.
@en
prefLabel
A phase II evaluation of briva ...... ecologic Oncology Group study.
@en
P2093
P2860
P1433
P1476
A phase II evaluation of briva ...... ecologic Oncology Group study.
@en
P2093
Albert J Bonebrake
Bradley J Monk
Carol Aghajanian
John K Chan
Krishnansu S Tewari
Michael Hicks
Pedro T Ramirez
Robert V Higgins
Stephanie Gaillard
P2860
P304
P356
10.1016/J.YGYNO.2017.05.033
P407
P577
2017-07-17T00:00:00Z